Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Douglas R Higgs has been announced as the new Director of the Medical Research Council (MRC) Weatherall Institute of Molecular Medicine (WIMM) at the University of Oxford, following the retirement of eminent immunologist Professor Sir Andrew McMichael.

Professor Higgs, who will continue his role as Director of the MRC Molecular Haematology Unit and Professor of Molecular Haematology at the University of Oxford, takes up his new role on October 1st 2012.

Of his appointment, Professor Higgs said: "It is a great honour to follow Sir David Weatherall and Sir Andrew McMichael as Director of the WIMM. The challenge will be to ensure that the Institute continues to lead the field of molecular medicine and remains true to its founding principles of applying first class basic science to important biomedical problems. In my view the key to this will be to recruit and retain the finest scientists, to provide a cutting edge infrastructure and to encourage adventurous science within the stimulating, collegiate environment created by previous Directors."



Similar stories

Annual WIMM fundraiser raises over £1000 for urology cancer research

Every year in early summer, a team of dedicated volunteers at the WIMM put together a series of fund-raising activities in aid of a local charity, which is often chosen because the beneficiary has links to staff and students at the Institute.

Programme grant won